Comparison

BAY-218 European Partner

Item no. HY-111449-100mg
Manufacturer MedChem Express
CASRN 2162982-11-6
Amount 100 mg
Quantity options 100 mg 10mM/1mL 10 mg 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.95
Formula C20H17ClFN3O3
Citations [1]Norbert Schmees, et al. 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides. WO2017202816A1.
Smiles O=C(C1=CC(C2=CC=C(Cl)C=C2)=NN(C3=CC=CC(F)=C3)C1=O)N[C@@H](C)CO
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias AHR antagonist 1
Similar products 2162982-11-6
Available
Product Description
BAY-218 (AHR antagonist 1) is an aryl hydrocarbon receptor (AHR) antagonist. BAY-218 has AHR inhibitory activity with an IC50 of 39.9 nM in in U87 glioblastoma cells. BAY-218 can be used for the research of cancer or conditions with dysregulated immune responses[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
401.82
Clinical Information
Phase 1
Manufacturers Research Area
Cancer; Inflammation/Immunology
Solubility
DMSO : ≥ 250 mg/mL
Target
Aryl Hydrocarbon Receptor
Manufacturers Target
Aryl Hydrocarbon Receptor
Manufacturers Pathway
Immunology/Inflammation
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close